HAPIMMUNE THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 09 Sept 2025)
What this means for you
Not registered yet, but its 14 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97590386
- Mark type
- Stylized text
- Filed
- 14 Sept 2022
- Published for opposition
- 01 Aug 2023
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
Owner
- AETHON THERAPEUTICS, INC., Long Island City, NY, US
- AETHON THERAPEUTICS, INC., NEW YORK, NY, US
- Sixth Sense Health LLC, NEW YORK, NY, US
Prosecution history
- 12 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2025 — SOU EXTENSION 4 GRANTED
- 09 Sept 2025 — SOU EXTENSION 4 FILED
- 09 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Mar 2025 — SOU EXTENSION 3 GRANTED
- 18 Mar 2025 — SOU EXTENSION 3 FILED
- 18 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2024 — SOU EXTENSION 2 GRANTED
- 10 Sept 2024 — SOU EXTENSION 2 FILED
- 10 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2024 — SOU EXTENSION 1 GRANTED